Overview

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and potential efficacy of deoxycholic acid injection compared to placebo for the reduction of submental fat (fat below the chin).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Treatments:
Deoxycholic Acid